Due Diligence

Technology, market, customers, competitors, business model, regulatory strategy, reimbursement – in the life sciences, you need to go a level deeper to understand the attractiveness and positioning of your target investment. DeciBio can get you there.

Our Experts

David Cavanaugh

David Cavanaugh

Carl Schoellhammer

Carl Schoellhammer

Stephane Budel

Schedule a Call

Related Client Results

All Client Results

Synthetic Oligonucleotides Market Sizing

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

No items found.

NIPT Menu and Technology Offerings

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

Voice-of-Customer Research

Pharma & Biotech

Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment

A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.

Voice-of-Customer Research

Pricing Strategy

Competitive Analysis

Clinical Diagnostics

Diagnostic Advisory Board

A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market

Voice-of-Customer Research

KOL Identification

Pre-due diligence research on a potential acquisition target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Pharma & Biotech

Cell and Gene Therapy Services Landscape Assessment

A top-10 scientific service provider wanted to quantify the size of the CGT services market and understand trends within

No items found.

Precision Medicine is evolving at a rapid pace

Discover how we can help